Business
Arius to move to the Toronto Stock Exchange
Arius to move to the Toronto Stock Exchange.
About this update from Affinity Metals Corp
[{"type":"text","content":"\n\n\n\n\nConditional Approval Received to Begin Trading\n\nTORONTO, July 12 /CNW/ - ARIUS Research Inc. (\"ARIUS\") (TSX-V: ARI),\ntoday announced that it has received approval to list its common shares on the\nToronto Stock Exchange (\"TSX\") conditional on receipt of final documentation.\nIt is expected that ARIUS' common shares will commence trading on the TSX at\nthe market open on or about July 24, 2006, under the symbol \"ARI\". In\nconjunction with its move to the TSX, ARIUS' common shares will be de-listed\nfrom and cease trading on the TSX Venture Exchange.\n\"The graduation to the TSX represents the achievement of a key milestone\nin ARIUS' corporate strategy and reflects our achievements in recent months,\"\nsaid Dr. David S. Young, President and Chief Scientific Officer of ARIUS,\n\"With our deal flow, significant financing and this graduation, ARIUS is\npositioned for growth and the transition to a clinical company.\"\n\nAbout ARIUS Research\nARIUS Research Inc. is a biotechnology company dedicated to personalizing\ncancer therapy through the discovery and development of novel anticancer\nmonoclonal antibodies (MAbs). Established in 1999, ARIUS has built a\nproprietary technology platform, FunctionFIRST(TM), that rapidly identifies\npowerful MAbs targeting a variety of cancer indications. This antibody\ngeneration engine has enabled ARIUS to assemble a growing pipeline, which is\nused for commercial collaborations and in-house development. ARIUS has ongoing\npartnerships with key biotechnology and drug development companies. The\ncompany is listed on the TSX Venture Exchange under the symbol \"ARI\".\n\nThe TSX Venture Exchange has not reviewed and does not accept\nresponsibility for the adequacy or accuracy of this statement.\n\nForward-Looking Statement\nCertain statements in this news release constitute \"forward-looking\nstatements\" within the meaning of the Private Securities Litigation Reform Act\nof 1995, which involve known and unknown risks, uncertainties and other\nfactors that may cause our actual results to be materially different from any\nfuture results, performance or achievements expressed or implied by such\nstatements. Forward-looking statements in this release include, but are not\nlimited to, ARIUS successfully advancing its new product programs as well as\nlicensing opportunities. These statem...